{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:00:41Z","timestamp":1791342041572,"version":"4.3.1"},"reference-count":37,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["agsjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J American Geriatrics Society"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>With better understanding of the pathologic processes of Alzheimer's disease, diagnostic methods have been developed to focus on specific biomarkers of disease detectable on brain imaging, cerebral spinal fluid, and, more recently, plasma. Although these tests do not establish a diagnosis of dementia, which requires a clinical evaluation, they can more precisely identify whether Alzheimer's disease is a contributing cause. The recent FDA approval of two blood\u2010based biomarkers and the availability of others, including direct\u2010to\u2010consumer tests, has led to the potential for widespread use in primary and specialty care. However, the currently available blood\u2010based biomarkers are more highly correlated with amyloid brain PET scans, which are less specific for symptomatic Alzheimer's disease, than with p\u2010tau brain PET scans, which are strongly associated with changes in cognition. The value of a positive or negative blood\u2010based biomarker depends on the test characteristics (e.g., sensitivity and specificity) of the specific test as well as the prevalence of the disease in the population. Clinicians ordering blood\u2010based biomarkers must decide their value in the care of individual patients and be prepared to interpret the test results to their patients.<\/jats:p>","DOI":"10.1111\/jgs.70384","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T05:30:02Z","timestamp":1773984602000},"page":"1543-1547","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Rational Use of Blood\u2010Based Biomarkers for Alzheimer's Disease: Navigating Between the Hope and the Hype"],"prefix":"10.1111","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1363-4745","authenticated-orcid":false,"given":"David B.","family":"Reuben","sequence":"first","affiliation":[{"name":"Department of Medicine David Geffen School of Medicine at UCLA  Los Angeles California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0461-8137","authenticated-orcid":false,"given":"Allison B.","family":"Chambliss","sequence":"additional","affiliation":[{"name":"Department of Pathology &amp; Laboratory Medicine David Geffen School of Medicine at UCLA  Los Angeles California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard J.","family":"Katz","sequence":"additional","affiliation":[{"name":"Department of Family Medicine David Geffen School of Medicine at UCLA  Los Angeles California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra S\u00e1nchez","family":"L\u00f3pez","sequence":"additional","affiliation":[{"name":"Department of Medicine David Geffen School of Medicine at UCLA  Los Angeles California USA"},{"name":"Department of Neurology David Geffen School of Medicine at UCLA  Los Angeles California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Hinman","sequence":"additional","affiliation":[{"name":"Department of Neurology David Geffen School of Medicine at UCLA  Los Angeles California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"e_1_2_4_2_1","unstructured":"\u201cNational Plan to Address Alzheimer's Disease: 2024 Update \u201d2025 https:\/\/aspe.hhs.gov\/sites\/default\/files\/documents\/dc2ff0be0e08df15971fce57cb8e5c7a\/napa\u2010national\u2010plan\u20102024\u2010update.pdf."},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13859"},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.02.018"},{"key":"e_1_2_4_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00401\u2010017\u20101717\u20107"},{"key":"e_1_2_4_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.70098"},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.0989"},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2020.12.005"},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.7817"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2310168"},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2025.0693"},{"key":"e_1_2_4_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.6619"},{"key":"e_1_2_4_13_1","unstructured":"\u201cThe Alzheimer's Diagnostic Database \u201d2025 https:\/\/alzdiagnostichub.org\/blood\u2010test\u2010performance\u2010database\/."},{"key":"e_1_2_4_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70828"},{"key":"e_1_2_4_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.70139"},{"key":"e_1_2_4_16_1","unstructured":"\u201cWhat is the Importance of ATN \u201d2026 https:\/\/images.go.labcorp.com\/Web\/LabcorpHCP\/%7Ba4ed5e65\u20109222\u201045f9\u2010a803\u20105b6d1a3de2f9%7D_546951_DX_WP_Neurobiomarkers_0923\u20103_Final.pdf."},{"key":"e_1_2_4_17_1","doi-asserted-by":"publisher","DOI":"10.58347\/tml.2025.1732b"},{"key":"e_1_2_4_18_1","unstructured":"\u201cBlood Test Interpretation Tool \u201d2025 https:\/\/amyloid.shinyapps.io\/interpret_BBM\/."},{"key":"e_1_2_4_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14536"},{"key":"e_1_2_4_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14338"},{"key":"e_1_2_4_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70535"},{"key":"e_1_2_4_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70173"},{"key":"e_1_2_4_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2025.0976"},{"key":"e_1_2_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2025.100310"},{"key":"e_1_2_4_25_1","unstructured":"\u201cAmerican Perspectives on Early Detection of Alzheimer's Disease in the Era of Treatment \u201d2025 https:\/\/www.alz.org\/getmedia\/3d226bf2\u20100690\u201048d0\u201098ac\u2010d790384f4ec2\/alzheimers\u2010facts\u2010and\u2010figures\u2010special\u2010report.pdf."},{"key":"e_1_2_4_26_1","unstructured":"\u201cRoche Presents New Data at CTAD Demonstrating its Growing Momentum in Diagnostics for Alzheimer's Disease \u201d2025 https:\/\/www.roche.com\/media\/releases\/med\u2010cor\u20102024\u201010\u201031b."},{"key":"e_1_2_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.03.005"},{"key":"e_1_2_4_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.13855"},{"key":"e_1_2_4_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/s43587\u2010024\u201000731\u2010y"},{"key":"e_1_2_4_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000001577"},{"key":"e_1_2_4_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14184"},{"key":"e_1_2_4_32_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000213675"},{"key":"e_1_2_4_33_1","unstructured":"\u201cA Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER\u2010ALZ 3) \u201d2025 https:\/\/clinicaltrials.gov\/study\/NCT05026866."},{"key":"e_1_2_4_34_1","unstructured":"\u201cAHEAD 3\u201045 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid \u201d2025 https:\/\/www.clinicaltrials.gov\/study\/NCT04468659."},{"key":"e_1_2_4_35_1","unstructured":"\u201cBlood Biomarkers and Early Detection of Alzheimer's Disease and Related Dementias \u201d2025 https:\/\/www.aafp.org\/pubs\/fpm\/issues\/2025\/0500\/alzheimers\u2010detection.pdf."},{"key":"e_1_2_4_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591\u2010025\u201003617\u20107"},{"key":"e_1_2_4_37_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.51849"},{"key":"e_1_2_4_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198403013100911"}],"container-title":["Journal of the American Geriatrics Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jgs.70384","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jgs.70384","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jgs.70384","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:06:05Z","timestamp":1781510765000},"score":1,"resource":{"primary":{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/10.1111\/jgs.70384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1111\/jgs.70384"],"URL":"https:\/\/doi.org\/10.1111\/jgs.70384","archive":["Portico"],"relation":{},"ISSN":["0002-8614","1532-5415"],"issn-type":[{"value":"0002-8614","type":"print"},{"value":"1532-5415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"2025-12-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}